CAS: 493035-82-8; 4-Hydroxy-2-Methylphenylboronic Acid

该化合物是一种有机有机体化合物,其特点是附着于苯球结构的碳酸碱性功能组群,该化合物一般显示白色到非白晶状表面,由于存在氢氧基组,在水和酒精等极溶剂中可溶解,而乙酸功能允许它参与各种化学反应,包括铃木结对有机合成和材料科学具有重要意义的铃木结扎.此外,该化合物可形成可逆的二醇复合体,使之在传感器应用和研制基于丙醇的药物方面有用,其结构特征有助于其在医药化学中的潜在应用,特别是在某些酶的抑制剂设计中.

结构式图片

欧盟法规

C&L通报

上下游产品

CAS号946427-03-8 3-甲基-4-(4,4,5,5...

合成工艺路线路线简述

  • 合成目标产物 (4-Hydroxy-2-Methyl)Phenylboronic Acid 主要起始原料 3-Methyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-yl)Phenol
  • (文献来源)合成步骤主要原料 3-Methyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-yl)Phenol
3-乙基-4-(4,4,5,5-四甲基-1,3,2-二噁硼烷-2-基)苯酚置于sodium Periodate,Ammonium Acetate,水体系中,用 丙酮 作为反应溶剂,化学反应 68.0H,以49%的收率获得产物4-羟基-2-甲基苯硼酸
参考文献:Farnesoid X Receptor Agonists
标题:Farnesoid X Receptor Agonists
摘要:本发明提供了新型的取代异噁唑化合物,药物组合物,治疗用途和制备方法.

海关参考信息

专利信息


专利号:US-9795613-B2
优先权日:2014-12-10
标题 :GLP-1 receptor modulators
发明人:BOEHM MARCUS F; MARTINBOROUGH ESTHER; MOORJANI MANISHA; TAMIYA JUNKO; HUANG LIMING; YEAGER ADAM R; BRAHMACHARY ENUGURTHI; FOWLER THOMAS; NOVAK ANDREW; MEGHANI PREMJI; KNAGGS MICHAEL; GLYNN DANIEL; MILLS MARK
权利人:CELGENE INT II SÀRL
摘要:Compounds are provided that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as methods of their synthesis, and methods of their therapeutic and/or prophylactic use. Such compounds can act as modulators or potentiators of GLP-1 receptor on their own, or with incretin peptides such as GLP-1(7-36) and GLP-1(9-36), or with peptide-based therapies, such as exenatide and liraglutide, and have the following general structure (where “ â€? represents either or both the R and S form of the compound): n nwhere A, B, C, Y 1 , Y 2 , Z, R 1 , R 2 , R 3 , R 4 , R 5 , W 1 , n, p and q are as defined herein.

专利号:US-9598430-B2
优先权日:2013-06-11
标 题 :GLP-1 receptor modulators
发明人:BOEHM MARCUS F; MARTINBOROUGH ESTHER; MOORJANI MANISHA; TAMIYA JUNKO; HUANG LIMING; YEAGER ADAM R; BRAHMACHARY ENUGURTHI; FOWLER THOMAS; NOVAK ANDREW; MEGHANI PREMJI; KNAGGS MICHAEL
权利人:RECEPTOS INC; CELGENE INT II SÀRL
摘要:Compounds are provided that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as methods of their synthesis, and methods of their therapeutic and/or prophylactic use. Such compounds can act as modulators or potentiators of GLP-1 receptor on their own, or with incretin peptides such as GLP-1(7-36) and GLP-1(9-36), or with peptide-based therapies, such as exenatide and liraglutide, and have the following general structure (where “ â€? represents either or both the R and S form of the compound): n nwhere A, B, C, Y 1 , Y 2 , Z, R 1 , R 2 , R 3 , R 4 , R 5 , W 1 , n, p and q are as defined herein.
北京普瑞东方化学技术有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.bjpurechem.com
企业联系电话:010-83993285👤
📞北京普瑞东方化学技术有限公司 ⚠️参考联系方式
联系人:冷先生
电话:010-83993285
手机:17610176018
传真:010-63370219
邮箱:sales@bjpurechem.com
通信地址: 北京市海淀区西三环北路50号院6号楼豪柏大厦1708室
邮编: 100048
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:北京市海淀区西三环北路50号院6号楼豪柏大厦1708室
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1055/s-0037-1609400
摘要:Green and Gold: Au Catalysis Improves Iododeboronation Scope. Synfacts. 2018 Mar 15;14(04):0365. doi: 10.1055/s-0037-1609400.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知